Defusing a time bomb.
出版信息
Nat Biotechnol. 2008 Oct;26(10):1051. doi: 10.1038/nbt1008-1051.
PMID:18846052
Abstract
摘要
相似文献
1
Defusing a time bomb.
Nat Biotechnol. 2008 Oct;26(10):1051. doi: 10.1038/nbt1008-1051.
2
Disclosure of industry payments to physicians.
N Engl J Med. 2008 Aug 7;359(6):559-61. doi: 10.1056/NEJMp0805309.
3
Forecast for the Physician Payment Sunshine Act: partly to mostly cloudy?
Ann Intern Med. 2014 Dec 16;161(12):915-6. doi: 10.7326/M14-1683.
4
The search for a cure: combating the problem of conflicts of interest that currently plagues biomedical research.
Iowa Law Rev. 2003 Oct;89(1):235-71.
5
Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.
N Engl J Med. 2013 May 30;368(22):2052-4. doi: 10.1056/NEJMp1305090.
6
The Sunshine Act--effects on physicians.
N Engl J Med. 2013 May 30;368(22):2054-7. doi: 10.1056/NEJMp1303523.
7
The Sunshine Act: how to avoid getting burned.
Fam Pract Manag. 2013 Sep-Oct;20(5):8-10.
8
CME shelter. Sunshine Act waiver for med ed payments may prompt marketing shift for product makers.
Mod Healthc. 2014 Jun 30;44(26):16-9.
9
The Sunshine Act: it's for real now.
WMJ. 2013 Apr;112(2):96-7.
10
Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
Wash Lee Law Rev. 2003 Winter;60(1):15-109.
引用本文的文献
1
Biosafety data as confidential business information.
PLoS Biol. 2013;11(3):e1001499. doi: 10.1371/journal.pbio.1001499. Epub 2013 Mar 5.
2
Industry and academia must avoid mismatching disclosures.
Nat Biotechnol. 2009 Jan;27(1):21. doi: 10.1038/nbt0109-21a.
Zotero 插件